Presented at ACT 2023
Dr. Mark Hoenerhoff, Senior Director of Investigative and Molecular Pathology at Inotiv, recently presented a Talking Tox Program at ACT 2023 on “Molecular Pathology in Investigative Toxicology Studies: Expanding Our Toolbox.” To learn more and download your copy of the presentation, complete the form.
This informative session highlighted the involvement of the pathologist throughout the study process, from study design through analysis of the pathology results, including adding on molecular endpoints in order to:
-
Understand mechanism of action/toxicity
-
Identify target cell populations and biodistribution of biologic compounds
-
Inform on safety and risk assessment
- Answer questions of importance in preclinical studies including identification of druggable targets
